{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:42:12Z","timestamp":1783132932420,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Annals of Otorhinolaryngology, Head and Neck Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.anorl.2020.08.009","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T08:00:53Z","timestamp":1597305653000},"page":"45-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Guidelines of the French Society of Otorhinolaryngology\u2013Head and Neck Surgery (SFORL), part II: Management of recurrent pleomorphic adenoma of the parotid gland"],"prefix":"10.1016","volume":"138","author":[{"given":"O.","family":"Malard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Courtade-Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Uro-Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Garrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mogultay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tronche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Varoquaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Righini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vergez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fakhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anorl.2020.08.009_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.oraloncology.2017.01.004","article-title":"Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence","volume":"66","author":"Valstar","year":"2017","journal-title":"Oral Oncol"},{"issue":"9","key":"10.1016\/j.anorl.2020.08.009_bib0200","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/hed.20613","article-title":"Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients","volume":"29","author":"Wittekindt","year":"2007","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.anorl.2020.08.009_bib0205","first-page":"E5","article-title":"Stepwise regional and distant progression of recurrent pleomorphic adenoma","volume":"40","author":"Chen","year":"2011","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.anorl.2020.08.009_bib0210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00405-007-0502-y","article-title":"Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature","volume":"265","author":"Redaelli de Zinis","year":"2008","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.anorl.2020.08.009_bib0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.anl.2019.02.010","article-title":"Recurrent benign pleomorphic adenoma of the parotid gland: Facial nerve identification and risk factors for facial nerve paralysis at re-operation","volume":"46","author":"Kuriyama","year":"2019","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"10.1016\/j.anorl.2020.08.009_bib0220","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0344-0338(11)80220-7","article-title":"WHO International histological classification of tumours. Tentative histological classification of salivary gland tumours","volume":"186","author":"Seifert","year":"1990","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.anorl.2020.08.009_bib0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.otohns.2005.04.008","article-title":"Recurrent pleomorphic adenoma of the parotid gland","volume":"133","author":"Leonetti","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anorl.2020.08.009_bib0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.anorl.2019.10.008","article-title":"Use of P-values and the terms \u201csignificant\u201d, \u201cnon-significant\u201d and \u201csuggestive\u201d in Abstracts in the European Annals of Otorhinolaryngology, Head & Neck Diseases","volume":"136","author":"Laccourreye","year":"2019","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.anorl.2020.08.009_bib0235","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.anorl.2019.11.003","article-title":"Cystic form of cervical lymphadenopathy in adults. Guidelines of the French Society of Otorhinolaryngology (short version). Part 2-etiological diagnosis procedure: Clinical and imaging assessment","volume":"137","author":"Santini","year":"2020","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"9","key":"10.1016\/j.anorl.2020.08.009_bib0240","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1017\/S0022215113001801","article-title":"Prognostic factors for secondary recurrence of pleomorphic adenoma: a 20-year, retrospective study","volume":"127","author":"Malard","year":"2013","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10.1016\/j.anorl.2020.08.009_bib0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/000348949510400203","article-title":"Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature","volume":"104","author":"Phillips","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"10.1016\/j.anorl.2020.08.009_bib0250","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0002-9610(96)00293-0","article-title":"An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland","volume":"172","author":"Renehan","year":"1996","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.anorl.2020.08.009_bib0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0266-4356(98)90748-3","article-title":"Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up","volume":"36","author":"Laskawi","year":"1998","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"12","key":"10.1016\/j.anorl.2020.08.009_bib0260","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s001060050179","article-title":"[Treatment of recurrent pleomorphic adenoma]","volume":"45","author":"Chilla","year":"1997","journal-title":"HNO"},{"key":"10.1016\/j.anorl.2020.08.009_bib0265","series-title":"Reccurent mixed tumors of the major and minor salivary glands. Color atlas and text of the salivary glands, diseasendisorders and surgery","author":"Norman","year":"1995"},{"issue":"1","key":"10.1016\/j.anorl.2020.08.009_bib0270","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00005537-200401000-00030","article-title":"Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study","volume":"114","author":"Stennert","year":"2004","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.anorl.2020.08.009_bib0275","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/cncr.10445","article-title":"Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland","volume":"94","author":"Glas","year":"2002","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.anorl.2020.08.009_bib0280","first-page":"1250","article-title":"Expression of hormonal receptor in patients with metastasizing pleomorphic adenoma of the major salivary gland; a clinicopathological report of three cases","volume":"92","author":"Larbcharoensub","year":"2009","journal-title":"J Med Assoc Thai"},{"issue":"7","key":"10.1016\/j.anorl.2020.08.009_bib0285","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3109\/00313020903071595","article-title":"Expressions of androgen receptor and its co-regulators in carcinoma ex pleomorphic adenoma of salivary gland","volume":"41","author":"Nakajima","year":"2009","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.anorl.2020.08.009_bib0290","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bjoms.2018.01.021","article-title":"Current thinking about the management of recurrent pleomorphic adenoma of the parotid: a structured review","volume":"56","author":"Kanatas","year":"2018","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.anorl.2020.08.009_bib0295","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.amjsurg.2004.11.008","article-title":"Recurrent pleomorphic adenoma of the parotid gland","volume":"189","author":"Zbaren","year":"2005","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.anorl.2020.08.009_bib0300","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hed.2890010310","article-title":"The pathology of head and neck tumors: salivary glands, part 3","volume":"1","author":"Batsakis","year":"1979","journal-title":"Head Neck Surg"},{"issue":"4","key":"10.1016\/j.anorl.2020.08.009_bib0305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9610(05)80547-1","article-title":"Whole organ sectioning of mixed parotid tumors","volume":"160","author":"Lam","year":"1990","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.anorl.2020.08.009_bib0310","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0714.2010.00956.x","article-title":"Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma","volume":"40","author":"Soares","year":"2011","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"10.1016\/j.anorl.2020.08.009_bib0315","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1600-0714.2009.00794.x","article-title":"Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma","volume":"38","author":"Soares","year":"2009","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"10.1016\/j.anorl.2020.08.009_bib0320","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/lary.24964","article-title":"Etiology and management of recurrent parotid pleomorphic adenoma","volume":"125","author":"Witt","year":"2015","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.anorl.2020.08.009_bib0325","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archotol.1986.03780110056007","article-title":"Surgical treatment of recurrent pleomorphic adenoma of the parotid gland","volume":"112","author":"Niparko","year":"1986","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.anorl.2020.08.009_bib0330","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ijporl.2007.07.019","article-title":"Pleomorphic adenoma of the parotid gland in children","volume":"71","author":"Rodriguez","year":"2007","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.anorl.2020.08.009_bib0335","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/01.MLG.0000166697.48868.8C","article-title":"Continuous facial nerve monitoring during pleomorphic adenoma recurrence surgery","volume":"115","author":"Makeieff","year":"2005","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.anorl.2020.08.009_bib0340","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1245\/s10434-010-1173-2","article-title":"Recurrent pleomorphic adenoma: results of surgical treatment","volume":"17","author":"Makeieff","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anorl.2020.08.009_bib0345","doi-asserted-by":"crossref","first-page":"156","DOI":"10.14639\/0392-100X-2307","article-title":"Repeatedly recurring pleomorphic adenoma: a therapeutic challenge","volume":"39","author":"Aro","year":"2019","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"12","key":"10.1016\/j.anorl.2020.08.009_bib0350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bjps.2014.09.030","article-title":"Pleomorphic adenomas: Post-operative radiotherapy is unnecessary following primary incomplete excision: A retrospective review","volume":"67","author":"Robertson","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.anorl.2020.08.009_bib0355","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0194-5998(99)70053-7","article-title":"Treatment of recurrent pleomorphic adenomas of the parotid gland","volume":"121","author":"Carew","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anorl.2020.08.009_bib0360","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00405-018-5205-z","article-title":"The role of adjuvant radiotherapy in management of recurrent pleomorphic adenoma of the parotid gland: a systematic review","volume":"276","author":"Mc Loughlin","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anorl.2020.08.009_bib0365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.canrad.2013.09.007","article-title":"[Radiation therapy for pleomorphic adenoma of the parotid]","volume":"18","author":"Jardel","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.anorl.2020.08.009_bib0370","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.0307-7772.2001.00530.x","article-title":"Radiation-induced cancers of the pharynx and larynx: a study of five clinical cases","volume":"27","author":"Malard","year":"2002","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.anorl.2020.08.009_bib0375","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1470-2045(08)70098-6","article-title":"Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies","volume":"9","author":"Veldeman","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anorl.2020.08.009_bib0380","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ctrv.2018.11.004","article-title":"Proton therapy for treatment of intracranial benign tumors in adults: A systematic review","volume":"72","author":"Lesueur","year":"2019","journal-title":"Cancer Treat Rev"}],"container-title":["European Annals of Otorhinolaryngology, Head and Neck Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879729620301915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879729620301915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:13:49Z","timestamp":1761819229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879729620301915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1879729620301915"],"URL":"https:\/\/doi.org\/10.1016\/j.anorl.2020.08.009","relation":{},"ISSN":["1879-7296"],"issn-type":[{"value":"1879-7296","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines of the French Society of Otorhinolaryngology\u2013Head and Neck Surgery (SFORL), part II: Management of recurrent pleomorphic adenoma of the parotid gland","name":"articletitle","label":"Article Title"},{"value":"European Annals of Otorhinolaryngology, Head and Neck Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anorl.2020.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}